Chevron vs. Johnson & Johnson: Which Dow Stock's Dividend Dominates?

Dividend stocks outperform non-dividend-paying stocks over the long run. It happens in good markets and bad, and the benefit of dividends can be quite striking -- dividend payments have made up about 40% of the market's average annual return from 1936 to the present day. But few of us can invest in every single dividend-paying stock on the market, and even if we could, we might find better gains by being selective. That's why we'll be pitting two of the Dow Jones Industrial Average's (DJINDICES: ^DJI  ) dividend payers against each other today to find out which Dow stock is the true dividend champion. Let's take a closer look at our two contenders now.

Tale of the tape
Chevron (NYSE: CVX  ) has only been a current Dow component since 2008, but it first joined way back in 1930, when it was still Standard Oil of California. Chevron's dubious 1999 removal hindered the index's growth for years, but investors who held on enjoyed gains of nearly 150% before the oil supermajor was reinstated. Chevron has ranked as America's third largest company on the Fortune 500 for several years running, a position befitting one of the largest integrated oil and gas companies in the world.

Johnson & Johnson (NYSE: JNJ  ) might be only a fraction of Chevron's size -- it was 41st on the most recent Fortune 500 -- but it's got every bit as much of a historical pedigree as one of the world's oldest and largest diversified medical products companies. J&J joined the Dow only two years before Chevron was taken off, in 1997, but it's remained a part of the index ever since.

Statistic

Chevron 

Johnson & Johnson

Market cap

$233.6 billion

$246.8 billion

P/E Ratio

8.9

23.5

Trailing 12-month profit margin

10.9%

15.2%

TTM free cash flow margin*

1.2%

17.3%

Five-year total return 

43.7%

59.9%

Source: Morningstar and YCharts.
*Free cash flow margin is free cash flow divided by revenue for the trailing 12 months.

J&J certainly has a margin advantage over Chevron, but the oil company is so inexpensive relative to the drugmaker that it could be a better investment solely on the possibility of higher valuations in the future. But will the market warm to Chevron, or are its glory days behind it?

Round one: endurance
Chevron's long streak of dividend payments isn't accurately recorded by any of today's most popular investor sites, but we know from historical records that the company has been paying out its profits to investors since the legendary 1911 Standard Oil antitrust decision that first created it. J&J has been paying shareholders back without interruption since 1944, which is certainly impressive in its own right, but not quite as venerable as Chevron's streak.

Winner: Chevron, 1-0.

Round two: stability
Paying dividends is well and good, but how long have our two companies been increasing their dividends? The same dividend payout year after year can quickly fall behind a rising market, and there's no better sign of a company's financial stability than a rising payout in a weak market (as long as it's sustainable, of course). Chevron recently joined the Dividend Aristocrats, as 2013 marks the 25th straight year it's increased its payouts. That can't quite hold a candle to J&J, which has been raising its payouts for a full half-century.

Winner: Johnson & Johnson, 1-1.

Round three: power
It's not that hard to commit to paying back shareholders, but are these payments enticing, or merely tokens? Let's take a look at how both companies have maintained their dividend yields over time as their businesses and share prices grow:

CVX Dividend Yield Chart

CVX Dividend Yield data by YCharts

The past five years have seen a lot of movement in Chevron's yield, but it's been relatively stable for two years. However, it was only quite recently that the oil company pulled ahead of J&J on this metric, and the two companies have been neck and neck for years. Let's call this one a ...

TIE.

Round four: strength
A stock's yield can stay high without much effort if its share price doesn't budge, so let's take a look at the growth in payouts over the past five years. If you bought in several years ago and the company's grown its payout substantially, your real yield is likely look much better than what's shown above.

CVX Dividend Chart

CVX Dividend data by YCharts

Winner: Chevron, 2-1.

Round five: flexibility
A company -- even one as well positioned as either of these -- needs to manage its cash wisely to ensure that there's enough available for tough times. Paying out too much of its free cash flow in dividends could be a warning sign that the dividend is at risk, particularly if business weakens. This next metric analyzes just how much of their free cash flows our two companies have paid out in dividends over the past four quarters:

CVX Cash Div. Payout Ratio TTM Chart

CVX Cash Div. Payout Ratio TTM data by YCharts

Winner: Johnson & Johnson, 2-2.

We've got to have a tiebreaker, as each company has posted two victories at the end of our five-round contest. Let's take a look at their debt-to-equity ratios, which can help us figure out how much flexibility each company really has with its cash:

CVX Debt to Equity Ratio Chart

CVX Debt to Equity Ratio data by YCharts

Winner: Chevron, 3-2.

Chevron pulls ahead, but just barely, after our overtime round. Don't discount J&J, though -- its superior free cash flow gives its dividend the appearance of greater sustainability, despite its ultimate loss today. Do you agree with this analysis, or would you rather own a drugmaker than an oil driller?

If you're an investor who prefers returns to rhetoric, you'll want to read The Motley Fool's new free report "5 Dividend Myths ... Busted!" In it, you'll learn which stocks provide premium growth and whether bigger dividends are better. Click here to keep reading.


Read/Post Comments (1) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On July 06, 2013, at 5:05 PM, jaybird43 wrote:

    I would rather own a drug maker. And I have no doubt that JNJ is in a class by itself in the field. Not so in energy. I prefer RDS with a higher yield, and lower p/e. And it's petigree matches that of Chevron. Debt to equity are about a draw.

Add your comment.

DocumentId: 2524970, ~/Articles/ArticleHandler.aspx, 7/25/2014 12:48:25 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement